Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by a larger pharmaceutical company in 2010
|
| gptkbp:ceo |
gptkb:John_Doe
|
| gptkbp:certification |
FDA approved
|
| gptkbp:distribution |
Nationwide
|
| gptkbp:employees |
500+
|
| gptkbp:focus |
Quality assurance
|
| gptkbp:founded |
gptkb:1960
|
| gptkbp:headquarters |
gptkb:New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rugby Laboratories
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:market |
gptkb:North_America
|
| gptkbp:mission |
To provide affordable medications
|
| gptkbp:parent_company |
Rugby Pharmaceutical Company
|
| gptkbp:partnerships |
Various healthcare organizations
|
| gptkbp:products |
Generic drugs
|
| gptkbp:research_and_development |
gptkb:battle
|
| gptkbp:services |
Contract manufacturing
|
| gptkbp:vision |
To be a leader in generic pharmaceuticals.
|
| gptkbp:website |
www.rugbylaboratories.com
|
| gptkbp:bfsParent |
gptkb:Oleptro
|
| gptkbp:bfsLayer |
7
|